The loss of erection can be attributed to various factors such as high blood pressure, aging, diabetes mellitus, smoking, alcoholism, depression, nerve or spinal cord damage, and low testosterone levels. This report contains market size and forecasts of Erectile Dysfunction in Global, including the following market information: Global Erectile Dysfunction Market Revenue, 2017-2022, 2023-2028, ($ millions) Global top five companies in 2021 (%) The global Erectile Dysfunction market was valued at 4995.6 million in 2021 and is projected to reach US$ 7328.5 million by 2028, at a CAGR of 5.6% during the forecast period. The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028. ED Drugs Segment to Reach $ Million by 2028, with a % CAGR in next six years. The global key manufacturers of Erectile Dysfunction include Eli Lilly, Pfizer, Bayer, Boston Scientific, Coloplast, Apricus Biosciences, Cristalia Produtos Quimicos Farmaceuticos, Dong-A Socio and Endo Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue. MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Erectile Dysfunction companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks. Total Market by Segment: Global Erectile Dysfunction Market, by Type, 2017-2022, 2023-2028 ($ millions) Global Erectile Dysfunction Market Segment Percentages, by Type, 2021 (%) ED Drugs ED Devices Global Erectile Dysfunction Market, by Application, 2017-2022, 2023-2028 ($ millions) Global Erectile Dysfunction Market Segment Percentages, by Application, 2021 (%) Congenital Patients Pathological Patients Global Erectile Dysfunction Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) Global Erectile Dysfunction Market Segment Percentages, By Region and Country, 2021 (%) North America US Canada Mexico Europe Germany France U.K. Italy Russia Nordic Countries Benelux Rest of Europe Asia China Japan South Korea Southeast Asia India Rest of Asia South America Brazil Argentina Rest of South America Middle East & Africa Turkey Israel Saudi Arabia UAE Rest of Middle East & Africa Competitor Analysis The report also provides analysis of leading market participants including: Key companies Erectile Dysfunction revenues in global market, 2017-2022 (estimated), ($ millions) Key companies Erectile Dysfunction revenues share in global market, 2021 (%) Further, the report presents profiles of competitors in the market, key players include: Eli Lilly Pfizer Bayer Boston Scientific Coloplast Apricus Biosciences Cristalia Produtos Quimicos Farmaceuticos Dong-A Socio Endo Pharmaceuticals Futura Medical Meda Pharmaceuticals Promedon SK Chemical Teva Pharmaceuticals Vivus Zephyr Surgical Implants (ZSI)
1 Introduction to Research & Analysis Reports 1.1 Erectile Dysfunction Market Definition 1.2 Market Segments 1.2.1 Market by Type 1.2.2 Market by Application 1.3 Global Erectile Dysfunction Market Overview 1.4 Features & Benefits of This Report 1.5 Methodology & Sources of Information 1.5.1 Research Methodology 1.5.2 Research Process 1.5.
